Literature DB >> 21164257

Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function.

Ranna El-Khairi, Alejandro Martinez-Aguayo, Bruno Ferraz-de-Souza, Lin Lin, John C Achermann.   

Abstract

The nuclear receptor transcription factors DAX-1 (NR0B1) and SF-1 (NR5A1) regulate many aspects of adrenal and reproductive development and function. Disruption of the genes encoding these factors can be associated with pediatric adrenal disease. DAX-1 mutations are classically associated with X-linked adrenal hypoplasia congenita, hypogonadotropic hypogonadism and impaired spermatogenesis. However, other phenotypes are also being reported, such as isolated mineralocorticoid insufficiency, premature sexual development, primary adrenal insufficiency in a 46, XX patient and late-onset X-linked adrenal hypoplasia congenita and/or hypogonadotropic hypogonadism. SF-1 mutations have also been associated with primary adrenal insufficiency, together with 46, XY disorders of sex development. However it is emerging that SF-1 changes are a relatively rare cause of primary adrenal failure in humans, and most individuals with SF-1 mutations have a spectrum of 46, XY disorders of sex development phenotypes. These conditions range from 46, XY females with streak gonads and müllerian structures, through children with ambiguous genitalia and inguinal testes, to severe penoscrotal hypospadias with undescended testes. Therefore, the human gonad appears to be more sensitive than the adrenal gland to loss of SF-1 function. This review will focus on the expanding range of phenotypes associated with DAX-1 and SF-1 mutations.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164257     DOI: 10.1159/000321213

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  16 in total

Review 1.  Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma.

Authors:  Derek P Simon; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2012-01-13       Impact factor: 4.102

2.  Lhx4 deficiency: increased cyclin-dependent kinase inhibitor expression and pituitary hypoplasia.

Authors:  Peter Gergics; Michelle L Brinkmeier; Sally A Camper
Journal:  Mol Endocrinol       Date:  2015-02-10

3.  Effects of monobutyl phthalate on steroidogenesis through steroidogenic acute regulatory protein regulated by transcription factors in mouse Leydig tumor cells.

Authors:  Y Hu; C Dong; M Chen; Y Chen; A Gu; Y Xia; H Sun; Z Li; Y Wang
Journal:  J Endocrinol Invest       Date:  2015-04-23       Impact factor: 4.256

Review 4.  Development of adrenal cortex zonation.

Authors:  Yewei Xing; Antonio M Lerario; William Rainey; Gary D Hammer
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 5.  Adrenal disorders in pregnancy.

Authors:  Silvia Monticone; Richard J Auchus; William E Rainey
Journal:  Nat Rev Endocrinol       Date:  2012-09-11       Impact factor: 43.330

6.  Steroidogenic factor 1 differentially regulates fetal and adult leydig cell development in male mice.

Authors:  Tatiana Karpova; Kumarasamy Ravichandiran; Lovella Insisienmay; Daren Rice; Valentine Agbor; Leslie L Heckert
Journal:  Biol Reprod       Date:  2015-08-12       Impact factor: 4.285

7.  Female-specific induction of rat pituitary dentin matrix protein-1 by GnRH.

Authors:  Marek Kucka; Ivana Bjelobaba; Samuel J H Clokie; David C Klein; Stanko S Stojilkovic
Journal:  Mol Endocrinol       Date:  2013-10-01

Review 8.  Regulation of adrenocortical steroid hormone production by RhoA-diaphanous 1 signaling and the cytoskeleton.

Authors:  Marion B Sewer; Donghui Li
Journal:  Mol Cell Endocrinol       Date:  2012-11-24       Impact factor: 4.102

Review 9.  New directions for the treatment of adrenal insufficiency.

Authors:  Gerard Ruiz-Babot; Irene Hadjidemetriou; Peter James King; Leonardo Guasti
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-06       Impact factor: 5.555

Review 10.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.